These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11520816)

  • 1. Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates.
    Das H; Wang L; Kamath A; Bukowski JF
    Blood; 2001 Sep; 98(5):1616-8. PubMed ID: 11520816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen.
    Miyagawa F; Tanaka Y; Yamashita S; Minato N
    J Immunol; 2001 May; 166(9):5508-14. PubMed ID: 11313389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells.
    Nishimura H; Hirokawa M; Fujishima N; Fujishima M; Miura I; Sawada K
    Int J Hematol; 2004 May; 79(4):369-76. PubMed ID: 15218968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.
    Kunzmann V; Bauer E; Feurle J; Weissinger F; Tony HP; Wilhelm M
    Blood; 2000 Jul; 96(2):384-92. PubMed ID: 10887096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.
    Wang H; Sarikonda G; Puan KJ; Tanaka Y; Feng J; Giner JL; Cao R; Mönkkönen J; Oldfield E; Morita CT
    J Immunol; 2011 Nov; 187(10):5099-113. PubMed ID: 22013129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
    Kabelitz D; Wesch D; Pitters E; Zöller M
    J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.
    Kato Y; Tanaka Y; Hayashi M; Okawa K; Minato N
    J Immunol; 2006 Jul; 177(2):877-84. PubMed ID: 16818742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate therapy.
    Licata AA
    Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.
    Kato Y; Tanaka Y; Tanaka H; Yamashita S; Minato N
    J Immunol; 2003 Apr; 170(7):3608-13. PubMed ID: 12646624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on bisphosphonates.
    Cohen SB
    Curr Rheumatol Rep; 2004 Feb; 6(1):59-65. PubMed ID: 14713403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 T cells.
    Wang H; Lee HK; Bukowski JF; Li H; Mariuzza RA; Chen ZW; Nam KH; Morita CT
    J Immunol; 2003 Apr; 170(7):3696-706. PubMed ID: 12646635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.
    Dhar S; Chiplunkar SV
    Cancer Immun; 2010 Nov; 10():10. PubMed ID: 21069948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells.
    Okuno D; Sugiura Y; Sakamoto N; Tagod MSO; Iwasaki M; Noda S; Tamura A; Senju H; Umeyama Y; Yamaguchi H; Suematsu M; Morita CT; Tanaka Y; Mukae H
    Front Immunol; 2020; 11():1405. PubMed ID: 32793196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of TCR gamma chain junctional region in prenyl pyrophosphate antigen recognition by gamma delta T cells.
    Bukowski JF; Morita CT; Band H; Brenner MB
    J Immunol; 1998 Jul; 161(1):286-93. PubMed ID: 9647235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for osteoporosis.
    Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity.
    Spada FM; Grant EP; Peters PJ; Sugita M; Melián A; Leslie DS; Lee HK; van Donselaar E; Hanson DA; Krensky AM; Majdic O; Porcelli SA; Morita CT; Brenner MB
    J Exp Med; 2000 Mar; 191(6):937-48. PubMed ID: 10727456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
    Chapurlat RD
    Treat Endocrinol; 2005; 4(2):115-25. PubMed ID: 15783248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of alendronate and risedronate in preventing and treating osteoporosis.
    Peters ML; Leonard M; Licata AA
    Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.